Hj. Zhu et al., APOPTOSIS IN HUMAN MONOCYTIC THP.1 CELLS INVOLVES SEVERAL DISTINCT TARGETS OF N-TOSYL-L-PHENYLALANYL CHLOROMETHYL KETONE (TPCK), Cell death and differentiation, 4(7), 1997, pp. 590-599
N-Tosyl-L-phenylalanyl chloromethyl ketone (TPCK), a chymotrypsin-like
serine protease inhibitor, affected apoptosis in human monocytic THP.
1 cells differently dependent on both the concentration used and the a
poptotic stimulus. TPCK (50-75 mu M) induced both biochemical and ultr
astructural changes characteristic of apoptosis, including proteolysis
of poly (ADP ribose) polymerase (PARP) and lamins together with forma
tion of large kilobase pair fragments of DNA, particularly of 30-50 an
d 200-300 kilobase pairs in length but without internucleosomal cleava
ge of DNA. The induction of apoptosis by TPCK also involved the proces
sing of CPP32 and Mch 3 to their catalytically active subunits. Benzyl
oxycarbonyl-Val-Ala-Asp (OMe) fluoromethyl ketone (Z-VAD.FMK), an ICE-
like protease inhibitor, completely prevented all the biochemical and
morphological changes induced by TPCK demonstrating the involvement of
ICE-like proteases in the execution phase of apoptosis. Lower concent
rations of TPCK (5-20 mu M) prevented internucleosomal cleavage of DNA
induced by other apoptotic stimuli. TPCK (10 mu M) inhibited cell dea
th induced by etoposide but potentiated that induced by cycloheximide
demonstrating that it differentially affected apoptosis in THP.1 cells
dependent on the stimulus used. These results are consistent with at
least three distinct TPCK targets, one being important for cell surviv
al, the second in facilitating internucleosomal cleavage of DNA and th
e third in the modulation of apoptosis induced by different apoptotic
stimuli.